bioAffinity Technologies receives Japanese patent notice for CyPath Lung

Go back to bioAffinity Technologies receives Japanese patent notice for CyPath Lung

bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm

October 8, 2026 8:00 AM EDT

Companys expanding intellectual property portfolio strengthens protection for its early lung cancer diagnostic in Asia

Patent strategy protects proprietary CyPath Lung flow cytometry+AI approach in international markets

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a... More